http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103405771-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 |
| filingDate | 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103405771-B |
| titleOfInvention | Medical composition and its use |
| abstract | The present invention proposes a kind of medical composition and its use.Described pharmaceutical composition comprises calcium channel blocker or its pharmaceutically acceptable salt, PDE5 inhibitor or its pharmaceutically acceptable salt and pharmaceutically acceptable excipient.According to the effect highly significant of pharmaceutical composition in prevention or treatment acute high altitude sickness of the embodiment of the present invention, and the combination action effect of this pharmaceutical composition in treatment altitude sickness is better than single PDE5 inhibitor, and the compositions of PDE5 inhibitor and calcium channel blocker has obvious synergistic function. |
| priorityDate | 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.